Yale School of Medicine

News and Video Search Results

News coverage

Ipsen appoints Keira Driansky as EVP, President of North America

GlobeNewswire 02 May 2024

*PARIS, FRANCE, 2 May 2024 - *Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty-driven biopharmaceutical company, announced..

IBA signs contract with Yale New Haven Health and Hartford HealthCare to install Proteus®ONE proton therapy solution in Connecticut, US
GlobeNewswire 02 May 2024
The New York Academy of Medicine Announces New Board of Trustee Members
GlobeNewswire 18 Apr 2024
Tenax Therapeutics to Host KOL Event: “LEVEL Setting: the Scientific Rationale for Levosimendan as a Potential First Treatment for PH-HFpEF, and the Ongoing Phase 3 LEVEL Study”
GlobeNewswire 09 Apr 2024
Notice convening the Annual General Meeting in BioPorto A/S
GlobeNewswire 04 Apr 2024

0 shares 1 views

You might like

Yale School of Medicine media coverage

Harvard Apparatus Regenerative Technology Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights

GlobeNewswire 02 Apr 2024

· Established a Research Collaboration with the McGowan Institute for Regenerative Medicine at the University of Pittsburgh to..

Gain Therapeutics Strengthens Management Team and Appoints Jonas Hannestad, M.D., Ph.D. as Chief Medical Officer
GlobeNewswire 01 Apr 2024
TransCode Therapeutics Announces Appointment of Daniel Vlock, M.D., as Chief Medical Officer
GlobeNewswire 28 Mar 2024
Clearmind Medicine Obtains Clearance for its Psychedelic- Based Alcoholism Clinical Trial
GlobeNewswire 13 Mar 2024
Hummingbird Bioscience and Dartmouth's Geisel School of Medicine to Co-Host 3rd Annual Virtual VISTA Symposium on March 27, 2024
PR Newswire Asia 13 Mar 2024

Advertisement

More coverage

Allyx Therapeutics Announces Positive Phase 1b Multiple Ascending Dose Data and Advances ALX-001 to Patients

GlobeNewswire 11 Mar 2024

Safety of ALX-001 Reinforced by New Data Presented at AD/PD™ 2024 Conference in LisbonTwo Oral Doses Selected for Further Study..